7Kirkwood J M, Strawderman M H, Ern-stoff M S, et al. Interferon alfa-2b adju-vant therapy of high-risk resected cuta-neous melanoma: the Eastern Coopera-tive Oncology Group Trial EST 1684 [J],Journal of clinical oncology, 1996, 14:7-17.
4Nord lurid J J, Bossy Boss RE. The biology of melanocytes[M]// Freinkel DT Woodley DT. The biology of skin new woik The Par- thenon pamlishing Croup,2011 :113-131.
5Chana J S，Br J Ophthalmol，1999年，83卷，110页
6Jay V，Arch Pathal Lab Med，1996年，120卷，497页
7Yang E，Blood，1996年，88卷，386页
8Egan KM, Seddon JM, Glynn RJ, et al. Edidemiologic aspects of uveal melanoma. Surv Ophthalmol,1988, 32: 239-251.
9Iscovich J, Ackerman C, Andreev H, et al. An epidemiological study of posterior uveal melanoma in Israel, 1961-1989. Int J Cancer,1995, 61: 291-295.
10Zimmerman LE, Sobin LH. Histologic typing of tumors of the eye and its a dnexa. In:WHO,ed. International Histological Classification of Tumors. Geneva: World Health Organization, 1980.112-116.
